...
首页> 外文期刊>European Journal of Pharmacology: An International Journal >Contribution of soluble intercellular adhesion molecule-1 to the migration of vascular smooth muscle cells.
【24h】

Contribution of soluble intercellular adhesion molecule-1 to the migration of vascular smooth muscle cells.

机译:可溶性细胞间粘附分子-1对血管平滑肌细胞迁移的贡献。

获取原文
获取原文并翻译 | 示例
           

摘要

Soluble intercellular adhesion molecule-1 (sICAM-1), a circulating form of ICAM-1, has been known to be involved in the development of vascular diseases that are associated with vascular smooth muscle cell migration, such as hypertension and atherosclerosis. Here we investigated the contributions of sICAM-1 in promoting vascular migration in rat aortic smooth muscle cells (RASMCs). sICAM-1 increased RASMC migration, and this response was stronger in spontaneously hypertensive rats (SHRs) than in Wistar Kyoto (WKY) rats. The CD11a, CD11b, and CD18 subunits of ICAM-1 receptors were expressed in both SHRs and WKY rats; however, the expression levels of CD18 and CD11b were greater in SHRs than in WKY rats. The neutralization of the receptor subunits with anti-CD11a and -CD18 antibodies abolished the sICAM-1-increased migration. The treatment of inhibitors of spleen tyrosine kinase (Syk) and p38 mitogen-activated protein kinase suppressed the sICAM-1-stimulated migration of RASMCs. sICAM-1 also increased the sprout formation in aortic rings on Matrigel, and this response was inhibited by treatment with these inhibitors. The results suggest that sICAM-1 play crucial roles in vascular cell function through Syk pathways, and that the altered responses of sICAM-1 in RASMCs from SHRs may be mediated by the increased expression of the CD18 receptor.
机译:众所周知,可溶性细胞间粘附分子1(sICAM-1)是ICAM-1的循环形式,参与了与血管平滑肌细胞迁移有关的血管疾病的发展,例如高血压和动脉粥样硬化。在这里,我们研究了sICAM-1在促进大鼠主动脉平滑肌细胞(RASMCs)中的血管迁移中的作用。 sICAM-1增加了RASMC迁移,并且该反应在自发性高血压大鼠(SHRs)中比在Wistar Kyoto(WKY)大鼠中更强。 ICAM-1受体的CD11a,CD11b和CD18亚基在SHRs和WKY大鼠中均表达。但是,SHR中CD18和CD11b的表达水平高于WKY大鼠。用抗CD11a和-CD18抗体中和受体亚基消除了sICAM-1增加的迁移。脾酪氨酸激酶(Syk)和p38丝裂原活化蛋白激酶抑制剂的治疗抑制了sICAM-1刺激的RASMC迁移。 sICAM-1还增加了Matrigel上主动脉环中的新芽形成,并且通过使用这些抑制剂进行治疗抑制了这种反应。结果表明,sICAM-1通过Syk途径在血管细胞功能中起关键作用,而SHRs在RASMC中sICAM-1响应的改变可能是由CD18受体表达的增加所介导的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号